awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33730396-1F5DAC6A-4261-461E-AEB0-B278F1C71190
Q33730396-1F5DAC6A-4261-461E-AEB0-B278F1C71190
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33730396-1F5DAC6A-4261-461E-AEB0-B278F1C71190
Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk.
P2860
Q33730396-1F5DAC6A-4261-461E-AEB0-B278F1C71190
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33730396-1F5DAC6A-4261-461E-AEB0-B278F1C71190
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fd2eb899551b0a37c3334835c1919be9746d9bc7
P2860
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.